You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 298 No. 4, July 25, 2007 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related letters
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Nutrition/ Malnutrition
 •Statistics and Research Methods
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Antioxidant Supplements and Mortality

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: Dr Bjelakovic and colleagues1 showed that there is no evidence from randomized trials that antioxidant supplements reduce mortality. However, the authors did not consider that the effects might vary among different population subgroups so that an average for a large group of people could be misleading.

Analyses of the large-scale Alpha-Tocopherol Beta-Carotene (ATBC) Cancer Prevention Study found substantial divergence in the effect of 50 mg/d of vitamin E on common cold incidence in elderly men. Among participants 72 years or older, who smoked heavily, and lived outside cities, use of vitamin E increased common cold incidence by 58% (95% confidence interval [CI], 23%-101%; 0.83 vs 0.53 colds per year), whereas in less-smoking city-dwellers it reduced common cold incidence by 46% (95% CI, –20% to –63%; 0.47 vs 0.86 colds per year).2 The effect of vitamin E on the incidence of pneumonia also diverged so that the risk . . . [Full Text of this Article]

Harri Hemilä, MD, PhD
harri.hemila@helsinki.fi
Department of Public Health
University of Helsinki
Helsinki, Finland



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED LETTERS

Antioxidant Supplements and Mortality

JAMA. ;298():400-400.
FULL TEXT  

Antioxidant Supplements and Mortality
, , and
JAMA. ;298():400-401.
FULL TEXT  

Antioxidant Supplements and Mortality
and
JAMA. ;298():401-402.
FULL TEXT  

Antioxidant Supplements and Mortality Reply
, , , , and
JAMA. ;298():402-403.
FULL TEXT  

RELATED ARTICLE

Mortality in Randomized Trials of Antioxidant Supplements for Primary and Secondary Prevention: Systematic Review and Meta-analysis
, , , , and
JAMA. ;297():842-857.
FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.